|
⚲
|
| Keyboard |
| Davis Stephanie A
✚
|
|
|---|---|
| CIK # | 0001771886 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001771886] | |
| 4 | [0001771886] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Davis Stephanie A | |
| Kinex Pharmaceuticals LLC | |
| Nogin Inc | |
| CuriosityStream Inc | |
| Software Acquisition Group Inc II |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2023-04-21 | Grant | 3,642 | $1.31 | 4,771 |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2023-01-13 | Grant | 25,538 | $0.19 | 4,852 |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-10-07 | Grant | 19,717 | $0.24 | 4,732 |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-08-03 | Option exercise | 8,750 | ||
|
Kinex Pharmaceuticals LLC ATNX
Restricted Stock Units · derivative
|
2022-08-03 | Option exercise | 8,750 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-07-20 | Grant | 7,138 | $0.67 | 4,782 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2022-06-28 | Grant | 17,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-04-08 | Grant | 6,316 | $0.75 | 4,737 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option L(Right to Buy) · derivative
|
2021-08-03 | Grant | 8,750 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Restricted Stock Units · derivative
|
2021-08-03 | Grant | 8,750 | $0.00 | |
|
CuriosityStream Inc CURI
Common Stock
|
2020-11-18 | Other | 20,000 | ||
|
CuriosityStream Inc CURI
Common Stock
|
2020-11-18 | Other | 3,737,500 | ||
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2020-09-10 | Buy | 10,000 | $11.35 | 113,500 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2020-06-05 | Grant | 17,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2019-06-26 | Buy | 10,000 | $18.00 | 180,000 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2019-04-03 | Grant | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2019-04-01 | Grant | 10,000 | $0.00 |